Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Clinical Study for Malignant Tumor-Induced Cachexia

NCT07008248 is registered in ClinicalTrials.gov with Changchun GeneScience Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07008248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07008248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Clinical Study for Malignant Tumor-Induced Cachexia
Lead sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Withdrawn
Start date
October 15, 2024
Completion date
December 31, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical characteristics and treatment outcomes of malignant tumor cachexia, multicenter observational study